ASCEND BY NTHRYS
Research Abroad Products

Molecular Pharmaceutics Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 200 project topics
Hepatic Metabolism Prediction and CYP3A4 Substrate Classification Engine
Machine learning service predicting hepatic clearance and metabolic routes using structural chemistry, in vitro assay data, and proprietary metabolism databases. Streamlines early formulation selection and reduces failed late-stage development programs.
Molecular Pharmaceutics PK Modeling Platforms Click to view more details →
Multi-Dose Steady-State PK Simulation and Dosing Regimen Optimizer
Automated platform simulating accumulation, steady-state attainment, and optimal dosing intervals for repeat-dose drugs using single-dose PK parameters. Supports label optimization and therapeutic drug monitoring (TDM) program development for revenue-generating clinical services.
Molecular Pharmaceutics PK Modeling Platforms Click to view more details →
BCS Prediction Software for Oral Bioavailability Assessment
Cloud-based platform that predicts drug solubility and permeability classifications using machine learning models trained on extensive pharmaceutical datasets. Accelerates formulation development timelines and reduces preclinical testing costs by 40-60% for pharmaceutical manufacturers.
Biopharmaceutics Classification System Analytics Click to view more details →
Permeability Testing Analytics Dashboard for ADME Screening
SaaS tool that integrates Caco-2, MDCK, and iPSC-derived intestinal model data to generate real-time permeability classifications and bioavailability predictions. Enables contract research organizations to process 300+ compounds monthly and increase client billing capacity by 35%.
Biopharmaceutics Classification System Analytics Click to view more details →
Solubility Profiling Platform with pH-Dependent Algorithm
Automated analytical service combining high-throughput solubility testing with proprietary pH mapping algorithms to classify drugs across BCS categories. Generates premium revenue streams for CROs while reducing solubility assessment turnaround from 6 weeks to 10 days.
Biopharmaceutics Classification System Analytics Click to view more details →
Formulation Optimization Engine Targeting BCS Class II Compounds
AI-driven platform that recommends optimal solubilization strategies and excipient combinations for poorly soluble drugs using historical formulation databases. Delivers faster market entry for pharmaceutical companies and creates recurring license fees exceeding $250k annually per client.
Biopharmaceutics Classification System Analytics Click to view more details →
Generic Drug Bioequivalence Prediction and Risk Scoring
Enterprise software that predicts BE success probability and formulation risks for generic drugs using BCS classification and in vitro-in vivo correlation modeling. Reduces failed bioequivalence studies by 25% and accelerates generic product approvals, creating significant time-to-market advantages.
Biopharmaceutics Classification System Analytics Click to view more details →
Biowaivers Assessment Tool for Regulatory Pathway Optimization
Compliance-focused platform that evaluates BCS eligibility for biowaiver applications under ICH guidelines and regional requirements using standardized dissolution testing data. Enables pharmaceutical companies to file simplified regulatory dossiers and reduce approval costs by $500k-$2M per product.
Biopharmaceutics Classification System Analytics Click to view more details →
Multi-species BCS Classifier for Preclinical-to-Clinical Translation
Integrated analytics service that applies human BCS classification alongside preclinical species-specific models to predict clinical performance from animal studies. Improves first-time clinical success rates and justifies development investments for contract research and biotech sponsors.
Biopharmaceutics Classification System Analytics Click to view more details →
Dissolution Profile Analytics with Machine Learning Correlation
SaaS platform that correlates dissolution data with BCS classification to predict bioavailability without conducting fed/fasted BE studies, using neural networks trained on 5000+ approved drugs. Generates consulting revenue and dissolution method optimization services worth $150k+ per engagement.
Biopharmaceutics Classification System Analytics Click to view more details →
Excipient Impact Assessment Tool for Formulation Strategy
Decision-support software that quantifies how excipients modify effective solubility and permeability for BCS classification reassessment of complex formulations. Helps pharmaceutical companies develop differentiated generic and branded formulations commanding premium margins through optimized bioavailability profiles.
Biopharmaceutics Classification System Analytics Click to view more details →
Regulatory Intelligence Platform for BCS-Based Submissions
Database and consulting service aggregating global regulatory precedents for BCS-based biowaiver approvals, dose adjustments, and formulation flexibility across FDA, EMA, and PMDA jurisdictions. Reduces regulatory uncertainty and generates recurring $50k-$200k annual subscriptions for pharmaceutical and generic manufacturers.
Biopharmaceutics Classification System Analytics Click to view more details →